Renewal of Provisional Consent to the Distribution of a New Medicine Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution inNew Zealand of the new medicine set out in the Schedule hereto: Schedule Name and Strength Form Name and Address of Manufacturer Proprietary Name(if any) Hepatitis B Immunoglobulin (Human) 16% w/v in 100IU and 400IU Note: This consent is effective from 25 February 1995 solution for IM injection (ampoule) CSL Limited, Parkville, Victoria, Australia Hepatitis B Immunoglobulin (Human) Dried Factor VIII Fraction 250IU in 10 mL Note: This consent is effective from 25 February 1995 powder for reconstitution for IV injection (vial) CSL Limited, Broadmeadows, Victoria, Australia AHF (High Purity) Dried Factor VIII Fraction Tetanus Immunoglobulin (Human) 16% w/v in 2501IU Note: This consent is effective from 25 February 1995 solution for IM injection (ampoule) CSL Limited, Parkville, Victoria, Australia Tetanus Immunoglobulin (Human) Zoster Immunoglobulin (Human) 320 mg in 2 mL Note: This consent is effective from 25 February 1995 solution for IM injection (ampoule) CSL Limited, Parkville, Victoria, Australia Zoster Immunoglobulin (Human) Rh(D) Immunoglobulin 625IU in 1 mL Note: This consent is effective from 25 February 1995 solution for IM injection (ampoule) CSL Limited, Parkville, Victoria, Australia Rh(D) Immunoglobulin Human Immunoglobulin G 3 g in 50 mL, 12 g in 200 mL and 30 g in 500 mL Note: This consent is effective from 25 February 1995 solution for IV injection (bottle) CSL Limited, Parkville, Victoria, Australia and CSL Limited, Broadmeadows, Victoria, Australia Intragam Human Immunoglobulin G 320 mg in 2 mL and 800 mg in 5 mL Note: This consent is effective from 25 February 1995 solution for IM injection (ampoule) CSL Limited, Parkville, Victoria, Australia Normal Immunoglobulin (Human) These medicines may only be distributed, supplied or used under conditions to be imposed from time to time by the Director-General of Health. Dated this 29th day of March 1995. DAVID SMYTH, Acting Director-General of Health, pursuant to delegation given by the Minister of Health on the 25th day of June 1993.